Back

5 years incident stroke, heart failure, acute myocardial infarction, and death in patients having undergone atrial fibrillation ablation according to BMI

16 April 2023 (08:00 - 20:00)
Organised by:
Congress Presentation Part of: Atrial Fibrillation - Round 1 - Stroke - OAC Epidemiology, Prognosis, Outcome EHRA Premium Access EHRA 2023

About the speaker

Photo
Doctor Jacob Toennesen

Gentofte University Hospital, Gentofte (Denmark)

7 More presentations in this session

Presentation thumbnail
Statin use improves the outcomes in patients with atrial fibrillation: A population-based study
Miss J. Huang (Hong Kong, HK)
Abstract Slides
Presentation thumbnail
Morphology-Voltage-P-wave-duration (MVP) score to select patients for continuous atrial fibrillation screening to prevent stroke
Doctor L. Xing (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study
Mr M. Grymonprez (Gent, BE)
Abstract Slides
Presentation thumbnail
How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide registry study.
Doctor M. Lehto (Helsinki, FI)
Abstract Slides
Presentation thumbnail
Racial differences in atrial fibrillation-related bleeding and mortality.
Doctor K. Dongseon (Anyang-Si- Gyeonggi-Do, KR)
Abstract Slides

Access the full session

Session thumbnail
Atrial Fibrillation - Round 1 - Stroke - OAC

The Event

Event poster

EHRA 2023

16 April - 18 April 2023

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources